This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) shed 3.82% to $19.40 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.28% to 10,475.25 and the Dow Jones Industrial Average rising 1.26% to 32,403.22. This was the stock's fifth consecutive day of losses. Novavax Inc. closed $217.10 short of its 52-week high ($236.50), which the company reached on December 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Replimune Group Inc. (REPL) fell 4.63% to $18.54, VBI Vaccines Inc. (VBIV) fell 4.46% to $0.64, and AnaptysBio Inc. (ANAB) fell 0.77% to $29.67. Trading volume (3.9 M) remained 1.0 million below its 50-day average volume of 5.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 4, 2022.
(END) Dow Jones Newswires
November 04, 2022 17:13 ET (21:13 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.